Allscripts (MDRX) Tops Q1 EPS by 1c

Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $346 million versus the consensus estimate of $348.49 million.Allscripts reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• Magyar Bancorp (MGYR) Reports Q2 EPS of $0.30
• Norfolk Southern (NSC) Misses Q1 EPS by 12c